The Company believes that the majority of described projects may be monetized in the predictable time frame. The Company believes that the best approach is to start from the development of non invasive medical devices.
Quickly apply for the appropriate permit licenses in US (FDA), in EU and Israel and so on…Meantime the Company will enter the market in China, Japan and some other Asian countries where permit licenses are not required or easily obtainable. Later the Company will enter other markets when appropriate approvals will be received.
The same approach will apply to the X-ray devices. The similar approach will be applicable to the nanotubes technologies.
The Company believes to be able reasonably quickly come to the critical mass and be able to self finance further developments